IP Library Granted Patent US 8,487,244
Granted Patent B2
US 8,487,244 · App. 13/271,435 · Granted Jul 16, 2013

Laser ablation electrospray ionization (LAESI) for atmospheric pressure, in vivo, and imaging mass spectrometry

Inventors: Akos Vertes (Reston, VA); Peter Nemes (Silver Spring, MD)
Assignee: The George Washington University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,487,244
App. No.
13/271,435
Granted
Jul 16, 2013
Kind
B2
Abstract

The field of the invention is atmospheric pressure mass spectrometry (MS), and more specifically a process and apparatus which combine infrared laser ablation with electrospray ionization (ESI).

Claims (35)

1. A laser ablation ionization device comprising:

a laser to emit energy at a sample to ablate the sample and generate an ablation plume;

an ionization source to generate a spray plume to intercept the ablation plume and generate ions; and

a mass spectrometer to detect the ions;

wherein the laser energy has a wavelength at an absorption band of an OH group, and

wherein the laser energy is coupled into the sample by water in the sample.

2. A laser ablation ionization device comprising:

a laser to emit energy at a sample to ablate the sample and generate an ablation plume;

an ionization source to generate a spray plume to intercept the ablation plume and generate ions; and

a mass spectrometer to detect the ions;

wherein the laser energy has a wavelength at an absorption band of one of an OH group, a CH group, and a NH group, and

wherein the laser energy is coupled into the sample at the wavelength of the absorption band.

3. The device of claim 2 , wherein the absorption band is the absorption band of the OH group, and the laser energy is coupled into the sample by water in the sample.

4. The device of claim 2 , wherein the ionization source is an electrospray apparatus, and wherein the spray plume is an electrospray lacking corona discharge.

5. The device of claim 2 comprising a target-to-spray axis distance from 10 mm to 30 mm.

6. The device of claim 2 , wherein the laser has a pulse length less than 100 nanoseconds.

7. The device of claim 2 , wherein the device has no influence on the sample's viability.

8. The device of claim 2 comprising one of reflection ablation geometry and transmission ablation geometry.

9. The device of claim 2 comprising a translation stage to position the sample, and wherein the device is configured to scan the sample's surface.

10. The device of claim 9 configured for in vivo spatial profiling of the sample.

11. The device of claim 9 configured for at least one of chemical imaging of the sample, biochemical imaging of the sample, and molecular imaging of the sample.

12. The device of claim 2 , wherein the sample is one of untreated whole blood and lyophilized human serum.

13. The device of claim 2 , wherein the sample is one of a living organism, a living tissue, and molecular components thereof.

14. The device of claim 2 , wherein the sample is in its native environment.

15. The device of claim 2 , wherein the sample is at one or more of ambient conditions, atmospheric pressure, and not at vacuum.

16. A method of laser ablation ionization comprising:

ablating a sample with a laser pulse to generate an ablation plume;

generating a spray plume with an ionization source;

intercepting the ablation plume with the spray plume to generate ions; and

detecting the ions with a mass spectrometer;

wherein the laser pulse has a wavelength at an absorption band of one of an OH group, a CH group, and a NH group, and wherein the laser pulse is coupled into the sample at the wavelength of the absorption band.

17. The method of claim 16 , wherein the absorption band is the absorption band of the OH group and the laser pulse is coupled into the sample by water in the sample.

18. The method of claim 16 comprising scanning the sample's surface by ablating a first area of the sample, moving the sample with a translation stage, and ablating a second area of the sample.

19. The method of claim 18 comprising in vivo spatial profiling of the sample's surface by generating a spatial distribution of molecular components in the sample.

20. The method of claim 18 comprising at least one of chemical imaging of the sample's surface, biochemical imaging of the sample's surface, and molecular imaging of the sample's surface.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 1, 2020
From: GEORGE WASHINGTON UNIVERSITY
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 053113/0992 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2011
From: VERTES, AKOS; NEMES, PETER
To: THE GEORGE WASHINGTON UNIVERSITY
Reel/Frame 027050/0151 →
Continuity (3)
Continuation 12176324 · Jul 18, 2008
Provisional Application 60951186 · Jul 20, 2007
Related Publication 20120025069A1 · Feb 2, 2012